Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 38 Records) |
Query Trace: Ulcer and CYP2C19[original query] |
---|
Efficacy of a Low-Dose Omeprazole-Based Triple-Therapy Regimen for Helicobacter pylori Eradication Independent of Cytochrome P450 Genotype : The Japanese MACH Study. Clinical drug investigation 2005 25 (5): 293-305. Kuwayama Hajime, Luk Gordon, Yoshida Shunichi, Nakamura Takefumi, Kubo Mitsuhiko, Uemura Naomi, Harasawa Shigeru, Kaise Mitsuru, Sanuki Eiko, Haruma Ken, Inoue Masaki, Shimatani Tomohiko, Mieno Hiroshi, Kawanishi Masahiro, Watanabe Hidenobu, Nakashima Mituyoshi, Nakazawa Sabu |
Endoscopic analysis of gastric ulcer after one week's treatment with omeprazole and rabeprazole in relation to CYP2C19 genotype. Digestive diseases and sciences 2008 Apr 53 (4): 933-7. Ando Takashi, Ishikawa Takeshi, Kokura Satoshi, Naito Yuji, Yoshida Norimasa, Yoshikawa Toshika |
Influence of lansoprazole and rabeprazole on mycophenolic acid pharmacokinetics one year after renal transplantation. Therapeutic drug monitoring 2008 Feb 30 (1): 46-51. Miura Masatomo, Satoh Shigeru, Inoue Kazuyuki, Kagaya Hideaki, Saito Mitsuru, Suzuki Toshio, Habuchi Tomono |
[Polymorphism of cytochrome P-450 gene in the light of Helicobacter pylori eradication efficiency]. Klinicheskaia meditsina 2009 87 (2): 35-9. Maev I V, Momynaliev K T, Oganesian T S, Govorun V M, Kucheriawy? Iu A, Selezneva O |
Blood concentration of pantoprazole sodium is significantly high in hepatogenic peptic ulcer patients, especially those with a poor CYP2C19 metabolism. Journal of digestive diseases 2009 Feb 10 (1): 55-60. Shao Jian Guo, Jiang Wen, Li Ke Qing, Lu Jian Rong, Sun Yuan Yu |
Pharmacogenetics of esomeprazole or rabeprazole-based triple therapy in Helicobacter pylori eradication in Hong Kong non-ulcer dyspepsia Chinese subjects. Journal of clinical pharmacy and therapeutics 2010 Jun 35 (3): 343-50. Lee V W Y, Chau T S, Chan A K W, Lee K K C, Waye M M Y, Ling T K W, Chan F K |
Correlation of CYP2C19 genetic polymorphisms with helicobacter pylori eradication in patients with cirrhosis and peptic ulcer. Journal of the Chinese Medical Association : JCMA 2010 Apr 73 (4): 188-93. Lay Chii-Shyan, Lin Chun-Jung, Lin Jiun-Ro |
Effects of CYP2C19, MDR1, and interleukin 1-B gene variants on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxicillin, and metronidazole. European journal of clinical pharmacology 2010 Jul 66 (7): 681-7. Gawro?ska-Szklarz Barbara, Siuda Andrzej, Kurzawski Mateusz, Bielicki Dariusz, Marlicz Wojciech, Dro?dzik Mar |
The effect of cytochrome P2C19 and interleukin-1 polymorphisms on H. pylori eradication rate of 1-week triple therapy with omeprazole or rabeprazole, amoxycillin and clarithromycin in Chinese people. Journal of clinical pharmacy and therapeutics 2010 Dec 35 (6): 713-22. Zhang L, Mei Q, Li Q S, Hu Y M, Xu J |
Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication. Pharmacotherapy 2011 Mar 31 (3): 227-38. Yang Jyh-Chin, Wang Hong-Long, Chern Herng-Der, Shun Chia-Tung, Lin Bor-Ru, Lin Chun-Jung, Wang Teh-Ho |
Ilaprazole for the treatment of duodenal ulcer: a randomized, double-blind and controlled phase III trial. Current medical research and opinion 2012 Jan 28 (1): 101-9. Wang Ling, Zhou Liya, Hu Haitang, Lin Sanren, Xia Jiel |
CYP2C19*17 gain-of-function polymorphism is associated with peptic ulcer disease. Clinical pharmacology and therapeutics 2012 Oct . Musumba CO, Jorgensen A, Sutton L, Van Eker D, Zhang E, O'Hara N, Carr DF, Pritchard DM, Pirmohamed M |
Modified sequential Helicobacter pylori eradication therapy using high dose omeprazole and amoxicillin in the initial phase in the extensive metaboliser Turkish patients for CYP2C19 polymorphism is ineffective. Acta gastro-enterologica Belgica 2014 Mar 77 (1): 3-7. Sezgin Orhan, Barlas I Omer, Uçbilek Enver, Yengel Emre, Altinta? Eng |
Low-Dose Aspirin-Associated Upper and Mid Gastrointestinal Tract Damage and Gene Polymorphism. Current pharmaceutical design 2015 Sep . Shiotani Akiko, Fujita Yoshihiko, Nishio Kazu |
Helicobacter pylori virulence genes and host genetic polymorphisms as risk factors for peptic ulcer disease. Expert review of gastroenterology & hepatology 2015 Oct 1-13. Miftahussurur Muhammad, Yamaoka Yosh |
Effects of the CYP2C19 genetic polymorphism on gastritis, peptic ulcer disease, peptic ulcer bleeding and gastric cancer. Asian Pacific journal of cancer prevention : APJCP 2014 15 (24): 10957-60. Jainan Wannapa, Vilaichone Ratha-Ko |
Effects of Genetic Polymorphisms of Cytochrome P450 Enzymes and MDR1 Transporter on Pantoprazole Metabolism and Helicobacter pylori Eradication. Basic & clinical pharmacology & toxicology 2016 Sep . Karaca R O, Kalkisim S, Altinbas A, Kilincalp S, Yuksel I, Goktas M T, Yasar U, Bozkurt A, Babaoglu M |
Modeling the cost-effectiveness of ilaprazole versus omeprazole for the treatment of newly diagnosed duodenal ulcer patients in China. Journal of medical economics 2016 Nov 19 (11): 1056-1060. Xuan J W, Song R L, Xu G X, Lu W Q, Lu Y J, Liu |
[HIGH FREQUENCY OF CYP2C19 ULTRARAPID METABOLIZERS IN RUSSIAN PATIENTS WITH PEPTIC ULCER]. E?ksperimental'nai?a? i klinicheskai?a? gastroe?nterologii?a? = Experimental & clinical gastroenterology 2015 (6): 11-5. Denisenko N P, Sychev D A , Sizova Zh M, Grachev A V, Velikolug K |
Urine metabolic ratio of omeprazole in relation to CYP2C19 polymorphisms in Russian peptic ulcer patients. Pharmacogenomics and personalized medicine 2017 10 10 253-259. Denisenko Natalia P, Sychev Dmitriy A, Sizova Zhanna M, Smirnov Valeriy V, Ryzhikova Kristina A, Sozaeva Zhannet A, Grishina Elena |
Biotransformation of Ilaprazole in Human Liver Microsomes and Human: Role of CYP3A4 in Ilaprazole Clearance and Drug-Drug Interaction. Drug metabolism and disposition: the biological fate of chemicals 2018 7 46 (10): 1453-1461. Pu Jie, Wang Fen, Tang Wei, Zhu Mings |
CYP3A and CYP2C19 activity in urine in relation to CYP3A4, CYP3A5, and CYP2C19 polymorphisms in Russian peptic ulcer patients taking omeprazole. Pharmacogenomics and personalized medicine 2018 11 107-112. Denisenko Natalia P, Sychev Dmitriy A, Sizova Zhanna M, Smirnov Valeriy V, Ryzhikova Kristina A, Sozaeva Zhannet A, Grishina Elena |
Pharmacogenetic testing by polymorphic markers 681G>A and 636G>A CYP2C19 gene in patients with acute coronary syndrome and gastric ulcer in the Republic of Sakha (Yakutia). Drug metabolism and personalized therapy 2018 May . Fedorinov Denis S, Mirzaev Karin B, Ivashchenko Dmitriy V, Temirbulatov Ilyas I, Sychev Dmitriy A, Maksimova Nadezda R, Chertovskih Jana V, Popova Nyurguiana V, Tayurskaya Ksenia S, Rudykh Zoya |
CYP2C19 polymorphism in relation to the pharmacotherapy optimization of commonly used drugs. Die Pharmazie 2018 11 73 (11): 619-624. Sienkiewicz-Oleszkiewicz B, Wiela-Hoje?ska |
Association between parental history of Helicobacter pylori treatment failure and treatment failure in the offspring. Journal of gastroenterology and hepatology 2019 7 34 (12): 2112-2117. Deguchi Hisato, Yamazaki Hajime, Yamamoto Yosuke, Fukuhara Shunic |
CYP2C19*2 polymorphism in Polish peptic ulcer patients. Pharmacological reports : PR 2018 Dec 71 (2): 272-275. Sa?agacka-Kubiak Aleksandra, ?ebrowska-Nawrocka Marta, Jele? Agnieszka, Mirowski Marek, Balcerczak E |
Effects of probiotics or broccoli supplementation on Helicobacter pylori eradication with standard clarithromycin-based triple therapy. The Korean journal of internal medicine 2019 12 35 (3): 574-581. Chang Young Woon, Park Yoo Min, Oh Chi Hyuk, Oh Shin Ju, Cho Jun-Hyung, Kim Jung-Wook, Jang Jae-You |
Drug-Drug Interaction between Tacrolimus and Vonoprazan in Kidney Transplant Recipients. Journal of clinical medicine 2021 9 10 (17): . Suzuki Yoshiharu, Yoshihashi Takuya, Takahashi Kazuhiro, Furuya Kinji, Ohkohchi Nobuhiro, Oda Tatsuya, Homma Masa |
Association of CYP2C19, TNF-?, NOD1, NOD2, and PPAR? polymorphisms with peptic ulcer disease enhanced by Helicobacter pylori infection. Saudi medical journal 2021 Jan 42 (1): 21-29. Al-Eitan Laith N, Almomani Fouad A, Al-Khatib Sohaib |
Effect and safety of anaprazole in the treatment of duodenal ulcers: a randomized, rabeprazole-controlled, phase III non-inferiority study. Chinese medical journal 2022 12 135 (24): 2941-2949. Zhu Huiyun, Pan Xue, Zhang Li, Sun Hongxin, Fan Huizhen, Pan Zhongwei, Huang Caibin, Shi Zhenwang, Ding Jin, Wang Qi, Du Yiqi, Lyu Nonghua, Li Zhaosh |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: